Form 4 for CRL Charles River Laboratories
Accepted 2023-05-17 00:00:00 ET · period of report 2023-05-15 · accession 0001127602-23-015972 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-05-17 | 2023-05-15 | CRL | FOSTER JAMES C | COB, Pres, CEO, Dir | G - Gift | $0.00 | -7,623 | 6,017 | -56% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-15 | G | D | 3,811 | $0.00 | 9,829 | I 2020 GRAT | — | — | (F1) The transaction was a gift of shares formerly held in a trust in the reporting person's name. The shares are no longer owned by the reporting person. |
| 2 | Common | Common Stock | 2023-05-15 | G | D | 3,812 | $0.00 | 6,017 | I 2020 GRAT | — | — | (F1) The transaction was a gift of shares formerly held in a trust in the reporting person's name. The shares are no longer owned by the reporting person. (F2) On 5/15/2023, 6,017 shares were transferred from the 2020 GRAT account to Direct holdings. |